Navigation Links
Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting
Date:9/23/2014

IRVINE, CA and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014

Proove Biosciences, the commercial and research leader in personalized medicine, presented industry leading research and data on the association between gender and opioid misuse this past weekend at the American Academy of Pain Management’ s 25th annual Clinical Meeting. The meeting took place in Phoenix, Arizona at the

Proove Biosciences presented their proprietary study on the linkage between gender and genetic predisposition to opioid misuse risk in chronic pain patients. Proove Biosciences’ very own Dr. Derrick Holman presented the research, titled the I.M.P.L.O.R.E Study (Investigation Measuring Predictive Levels of Opioid Risk by Evaluating Genotype versus Common Screening Tools). Proove Biosciences has been presenting research and data at major industry conferences and events over the last two years.

This year’s annual meeting offers attendees and industry practitioners engaging presentations by leading researchers and experts in the field of integrative pain management. The conference aims to address the benefits of using an integrative model of care to manage pain, as well as explain how research is supporting integrative pain management techniques. Additionally, the conference will feature insight on how to assess pain using a variety of strategies, and how to create treatment plans for patients with chronic pain that incorporate lifestyle and mind-body therapies.

“Our research has garnered significant attention from pain medicine and addiction professionals because they understand the importance of genetic variables in determining the most effective treatments for their patients,” stated Brian Meshkin, President of Proove Biosciences. “The I.M.P.L.O.R.E. Study was an investigation involving 1,629 chronic pain patients who were genotyped using Proove’s proprietary Narcotic Risk Profile. This observation study will help us better understand the link between addiction, treatment, and gender. We are excited to share our findings with the professionals at the American Academy of Pain Management’s 25th annual meeting, and look forward demonstrating how our genetic testing has been helping physicians better understand the individual variables associated with pain and pain treatment.”

About Proove Biosciences

Our mission is to change the future of medicine by providing proof to improve healthcare decisions. We envision a future when clinicians will know how patients are likely to respond to medications before writing a prescription. We believe genetic testing can provide such knowledge. Using a simple cheek swab, Proove performs proprietary genetic tests in its CLIA-certified laboratory. Healthcare providers use the results to evaluate how their patients will metabolize medications, and to screen for the likelihood of medication misuse.

Founded in 2009 with offices in Southern California and the Baltimore-Washington metropolitan area, Proove Biosciences is the leader in genetics-related personalized pain medicine research with hundreds of clinical research sites across the U.S. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at http://www.prweb.com/releases/2014/09/prweb12191640.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
4. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
5. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
8. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
9. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
10. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
11. Proove Biosciences Exhibits Industry Leading Data and Research at PAINWeek 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the leading provider ... they will be exhibiting at Biotech Week Boston , September 4th – 7th ... Pulse platform, healthcare’s most powerful all in one marketing solution. Pulse is ...
(Date:8/9/2018)... Pa. (PRWEB) , ... August 09, 2018 , ... ... Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development ... 50 years. The review article was published online on August 9, 2018 and ...
(Date:8/7/2018)... ... ... PetPace , the makers of a smart health-monitoring collar for pets, and ... a groundbreaking study to identify and eventually predict problems and complications affecting pregnant dogs. ... by PetPace and conducted by Dr. Smadar Tal, DVM, DACT, DECAR, a veterinarian specializing ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... marked molecular quality controls to its expanding CE/IVD product inventory. , “We are ... expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully support and provide ...
Breaking Biology Technology:
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... addition of heart health innovator Boston Heart Diagnostics to its Lifestyle Medicine Corporate ... health, a sustainable health care system and a sustainable world. , Boston ...
(Date:8/1/2018)... ... August 01, 2018 , ... Dr. Asher Kimchi, Founder and Chairman ... of the 2018 IAC Awards at the 23rd World Congress on Heart Disease held ... four faculty to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with ...
(Date:8/1/2018)... & GILBERT, Ariz. (PRWEB) , ... July 31, ... ... A. May Father of Stevia Awards at Global Conference , Awards honor late ... May, Ph.D., president of Wisdom National Brands, presented prestigious stevia awards to a ...
Breaking Biology News(10 mins):